Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
259 hedge funds and large institutions have $6.03B invested in Athenahealth, Inc. in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 30 closing their positions.
90% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 30
33% more call options, than puts
Call options by funds: $51.1M | Put options by funds: $38.4M
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
10% more funds holding
Funds holding: 235 → 259 (+24)
0% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 78
3% less capital invested
Capital invested by funds: $6.19B → $6.03B (-$168M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$41.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.2M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$21.5M |
| 4 |
Millennium Management
New York
|
+$16.4M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$15.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$230M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$41.2M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$36.4M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$35.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$34.5M |
ATHN Hedge Fund Activity: Q1 2018 in Review
259 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q1 2018, worth a combined $6.03B — down 2.7% from $6.19B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new ATHN positions and 30 closed out — a net gain of 27 holders — while 78 added to existing stakes and 78 trimmed.
The largest buyer was Ameriprise, adding an estimated $41.2M. The largest seller was Fidelity Investments, cutting an estimated $230M.
- 259 institutional investors held Athenahealth, Inc. (ATHN) as of Q1 2018, up from 235 in Q4 2017.
- Funds reported $6.03B of Athenahealth, Inc. stock for Q1 2018, down 2.7% quarter-over-quarter.
- 57 funds opened new Athenahealth, Inc. positions in Q1 2018 and 30 closed out, a net change of +27 holders.
- The largest Athenahealth, Inc. buyer in Q1 2018 was Ameriprise, an estimated $41.2M added.
- The largest Athenahealth, Inc. seller in Q1 2018 was Fidelity Investments, an estimated $230M sold.
Based on aggregated 13F filings for Q1 2018.